You have 9 free searches left this month | for more free features.

Diazoxide

Showing 1 - 25 of 41

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hyperinsulinemia, Insulin Resistance, Non-Alcoholic Fatty Liver Disease Trial in New York (Diazoxide oral suspension, 1 mg per

Recruiting
  • Hyperinsulinemia
  • +3 more
  • Diazoxide oral suspension, 1 mg per kg per dose
  • +3 more
  • New York, New York
    Columbia University Irving Medical Center
Feb 6, 2023

Diabetes, Type 2, Glucose, High Blood, Glucose Metabolism Disorders (Including Diabetes) Trial in Bronx (Diazoxide, Placebo)

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • +2 more
  • Diazoxide
  • Placebo
  • Bronx, New York
    Albert Einstein College of Medicine
Jun 10, 2022

Prader-Willi Syndrome Trial (DCCR)

Not yet recruiting
  • Prader-Willi Syndrome
  • (no location specified)
Jan 26, 2023

Diabetes, Type 1, Hypoglycemia, Hypoglycemia Unawareness Trial in Bronx (Naloxone, Diazoxide, Placebo (for Naloxone))

Suspended
  • Diabetes Mellitus, Type 1
  • +2 more
  • Bronx, New York
    Albert Einstein College of Medicine
Feb 3, 2022

Myocardial Stunning Trial in Baltimore (IV Diazoxide, Placebo)

Not yet recruiting
  • Myocardial Stunning
  • IV Diazoxide
  • Placebo
  • Baltimore, Maryland
    Johns Hopkins Hospital
Sep 21, 2021

Type 2 Diabetes, Glucose Metabolism Disorders, Glucose, High Blood Trial in Bronx (Diazoxide, Placebo)

Active, not recruiting
  • Type 2 Diabetes
  • +2 more
  • Diazoxide
  • Placebo
  • Bronx, New York
    Albert Einstein College of Medicine
Nov 11, 2022

Gastro-enteropancreatic Neuroendocrine Tumor Trial (Pasireotide, Diazoxide)

Withdrawn
  • Gastro-enteropancreatic Neuroendocrine Tumor
  • (no location specified)
Feb 17, 2022

Type 2 Diabetes, Glucose Metabolism Disorders, Glucose, High Blood Trial in Bronx (Diazoxide, Nicotinic acid, Placebo)

Recruiting
  • Type 2 Diabetes Mellitus
  • +2 more
  • Diazoxide
  • +2 more
  • Bronx, New York
    Albert Einstein College of Medicine
Jun 15, 2022

Prader-Willi Syndrome Trial (DCCR)

Withdrawn
  • Prader-Willi Syndrome
  • (no location specified)
Jul 29, 2021

Type 1 Diabetes Trial in Dundee (Diazoxide, Placebo)

Completed
  • Type 1 Diabetes
  • Diazoxide
  • Placebo
  • Dundee, United Kingdom
    NHS Tayside
Oct 11, 2019

Congenital Hyperinsulinism Trial in Worldwide (dasiglucagon)

Enrolling by invitation
  • Congenital Hyperinsulinism
  • Aurora, Colorado
  • +9 more
Jan 30, 2023

Glycemic Patterns After Bariatric Surgery and High Glycemic

Recruiting
  • Bariatric Surgery
  • Glucose monitoring with flash glucose monitor
  • Rio De Janeiro, Brazil
    Laboratory for Clinical and Experimental Research on Vascular Bi
Feb 11, 2023

Pattern of Metabolic Causes of Neonatal Hypoglycemia

Not yet recruiting
  • Neonatal Hypoglycemia
  • Metabolic Disease
    • (no location specified)
    Jul 24, 2023

    Obesity and Bariatric Surgery According toBiopsychosocial

    Recruiting
    • Obesity
    • +4 more
    • Holter Faros 360° EKG (Bittium Corporation)
    • +4 more
    • Rio De Janeiro, Rio De Janeiro, Brazil, Brazil
      Laboratory for Clinical and Experimental Research on Vascular Bi
    Jul 10, 2023

    Hyperinsulinism-Hyperammonemia Syndrome Trial in Philadelphia (Vitamin E)

    Not yet recruiting
    • Hyperinsulinism-Hyperammonemia Syndrome
    • Vitamin E
    • Philadelphia, Pennsylvania
      Children's Hospital of Philadelphia
    Aug 17, 2022

    Hypoglycemia, Newborn Morbidity Trial in Boston (Continuous Glucose Monitoring)

    Terminated
    • Hypoglycemia
    • Newborn Morbidity
    • Continuous Glucose Monitoring
    • Boston, Massachusetts
      Boston Children's Hospital
    Oct 19, 2021

    Hypothalamic Obesity Trial in Toronto (Diazoxide, Metformin)

    Completed
    • Hypothalamic Obesity
    • Toronto, Ontario, Canada
      The Hospital for Sick Children
    Nov 13, 2017

    Post-bariatric Hypoglycemia Trial in Boston (glucagon, Closed loop glucagon pump)

    Completed
    • Post-bariatric Hypoglycemia
    • Boston, Massachusetts
      Joslin Diabetes Center
    Aug 7, 2022

    Congenital Hyperinsulinism, Hyperinsulinism, Persistent Hyperinsulinemic Hypoglycemia of Infancy Trial in Philadelphia (F-DOPA,

    Completed
    • Congenital Hyperinsulinism
    • +4 more
    • Philadelphia, Pennsylvania
      Children's Hospital of Philadelphia
    Feb 26, 2020

    Depression Trial run by the NIMH (Diazoxide, Placebo)

    Terminated
    • Depression
    • Diazoxide
    • Placebo
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Sep 12, 2017

    PCOS Trial in Richmond (diazoxide)

    Completed
    • PCOS
    • diazoxide
    • Richmond, Virginia
      General Clinical Research Center
    Jun 9, 2017

    Polycystic Ovary Syndrome Trial in San Diego (3-D Ultrasound, recombinant human chorionic gonadotropin, Recombinant human

    Completed
    • Polycystic Ovary Syndrome
    • 3-D Ultrasound
    • +5 more
    • San Diego, California
      UCSD Medical Center
    May 1, 2018

    Hypertriglyceridemia Trial (Diazoxide choline, Diazoxide choline high dose)

    Withdrawn
    • Hypertriglyceridemia
    • Diazoxide choline
    • Diazoxide choline high dose
    • (no location specified)
    Aug 30, 2016

    Prader-Willi Syndrome Trial (Diazoxide choline controlled-release tablet)

    Unknown status
    • Prader-Willi Syndrome
    • Diazoxide choline controlled-release tablet
    • (no location specified)
    Sep 7, 2016

    Hyperinsulinism Trial in Philadelphia (Sirolimus)

    Withdrawn
    • Hyperinsulinism
    • Philadelphia, Pennsylvania
      The Children's Hospital of Philadelphia
    Jun 12, 2018